Fluorinated dendrimers as imaging agents for ¹⁹F MRI.

¹⁹F is the second most sensitive stable nucleus for magnetic resonance imaging (MRI). Because there is no endogenous ¹⁹F signal, ¹⁹F MRI is much more suited for quantification and tracking than ¹H MRI. However, ¹⁹F MRI is not in clinical use because in spite of more than three decades of research, there are no approved ¹⁹F imaging agents. New approaches and new methodologies are needed to move the field forward. Water-soluble fluorinated dendrimers present a promising alternative to conventional perfluorocarbon emulsions. This article outlines recent development of fluorinated dendrimers as ¹⁹F imaging agents. This is not meant to be a comprehensive review of ¹⁹F imaging agents, for which there is an excellent recent review by Knight et al. Rather, the article aims to give an insider's account on research efforts in this exciting and challenging field.

[1]  Samuel A Wickline,et al.  In vivo “hot spot” MR imaging of neural stem cells using fluorinated nanoparticles , 2008, Magnetic resonance in medicine.

[2]  I. Wilkinson,et al.  Influence of Human Serum Albumin on Longitudinal and Transverse Relaxation Rates (R1 and R2) of Magnetic Resonance Contrast Agents , 2006, Investigative radiology.

[3]  D. Curran,et al.  Stereoisomer libraries: total synthesis of all 16 stereoisomers of the pine sawfly sex pheromone by a fluorous mixture-synthesis approach. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  I. Kuprov,et al.  Lanthanide Complexes as Paramagnetic Probes for 19F Magnetic Resonance , 2012 .

[5]  D. Tomalia.  Architecturally Driven Properties Based on the Dendritic State , 2001 .

[6]  Y. Nosé.  Is there a role for blood substitutes in civilian medicine: a drug for emergency shock cases? , 2004, Artificial organs.

[7]  Eric T Ahrens,et al.  In vivo imaging platform for tracking immunotherapeutic cells , 2005, Nature Biotechnology.

[8]  D. Washburn,et al.  Parameter optimization and calibration of 19F magnetic resonance imaging at 1.5 Tesla. , 1991, Magnetic resonance imaging.

[9]  Martin W. Brechbiel,et al.  Dendrimer-based macromolecular MRI contrast agents: characteristics and application. , 2003 .

[10]  Y. Nagasaki,et al.  On-off regulation of 19F magnetic resonance signals based on pH-sensitive PEGylated nanogels for potential tumor-specific smart 19F MRI probes. , 2007, Bioconjugate chemistry.

[11]  R R Price,et al.  In vivo fluorine‐19 MR imaging: Relaxation enhancement with Gd‐DTPA , 1994, Journal of magnetic resonance imaging : JMRI.

[12]  Eric Niiler.  Setbacks for blood substitute companies , 2002, Nature Biotechnology.

[13]  V. Soloshonok,et al.  Concise asymmetric synthesis of configurationally stable 4-trifluoromethyl thalidomide. , 2009, Future medicinal chemistry.

[14]  P M Joseph,et al.  Fluorinated blood substitute retention in the rat measured by fluorine-19 magnetic resonance imaging. , 1992, Investigative radiology.

[15]  E. Jeong,et al.  Sol and gel states in peptide hydrogels visualized by Gd(III)‐enhanced magnetic resonance imaging , 2011, Biopolymers.

[16]  Jeffrey S. Moore,et al.  Rapid Construction of Large‐size Phenylacetylene Dendrimers up to 12.5 Nanometers in Molecular Diameter , 1993 .

[17]  Y. Yu,et al.  Fluorinated paramagnetic chelates as potential multi-chromic 19F tracer agents. , 2011, Chemical communications.

[18]  G. Newkome,et al.  Dendrimers derived from 1 → 3 branching motifs. , 2010, Chemical reviews.

[19]  Xenophon Papademetris,et al.  Self-assembly of pH-responsive fluorinated dendrimer-based particulates for drug delivery and noninvasive imaging. , 2009, Biomaterials.

[20]  H. Billiet,et al.  Retention and selectivity characteristics of a non-polar perfluorinated stationary phase for liquid chromatography , 1981 .

[21]  I. Horváth,et al.  Facile Catalyst Separation Without Water: Fluorous Biphase Hydroformylation of Olefins , 1994, Science.

[22]  M. Port,et al.  Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review , 2006, Fundamental & clinical pharmacology.

[23]  P. Antich,et al.  Perfluorocarbon imaging in vivo: a 19F MRI study in tumor-bearing mice. , 1989, Magnetic resonance imaging.

[24]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[25]  Y. Struchkov,et al.  General method for the synthesis of enantiomerically pure β-hydroxy-α-amino acids, containing fluorine atoms in the side chains. Case of stereochemical distinction between methyl and trifluoromethyl groups. X-Ray crystal and molecular structure of the nickel(II) complex of (2S,3S)-2(trifluoromethyl) , 1993 .

[26]  Arend Heerschap,et al.  Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging. , 2010, Biomaterials.

[27]  P. Antich,et al.  Fluorinated proteins as potential 19F magnetic resonance imaging and spectroscopy agents. , 1994, Bioconjugate chemistry.

[28]  A. Whittaker,et al.  Functional hyperbranched polymers: toward targeted in vivo 19F magnetic resonance imaging using designed macromolecules. , 2010, Journal of the American Chemical Society.

[29]  Andreas M. Nyström,et al.  Amphiphilic hyperbranched fluoropolymers as nanoscopic 19F magnetic resonance imaging agent assemblies. , 2008, Biomacromolecules.

[30]  J A Frank,et al.  Synthesis and relaxometry of high‐generation (G = 5, 7, 9, and 10) PAMAM dendrimer‐DOTA‐gadolinium chelates , 1999, Journal of magnetic resonance imaging : JMRI.

[31]  U. Gross,et al.  Perfluorocarbons: chemically inert but biologically active? , 1991 .

[32]  Xuyi Yue,et al.  Synthesis and characterization of fluorinated conjugates of albumin , 2013 .

[33]  Laura L Hyland,et al.  Avoiding steric congestion in dendrimer growth through proportionate branching: a twist on da Vinci's rule of tree branching. , 2012, The Journal of organic chemistry.

[34]  J. Fréchet,et al.  Convergent dendrons and dendrimers: from synthesis to applications. , 2001, Chemical reviews.

[35]  D. Curran,et al.  Fluorous Mixture Synthesis: A Fluorous-Tagging Strategy for the Synthesis and Separation of Mixtures of Organic Compounds , 2001, Science.

[36]  P. Antich,et al.  Novel molecular probes for 19F magnetic resonance imaging: synthesis & characterization of fluorinated polymers , 1992 .

[37]  Elias Fattal,et al.  Liquid Perfluorocarbons as Contrast Agents for Ultrasonography and 19F-MRI , 2009, Pharmaceutical Research.

[38]  R. Geyer.  Fluorocarbon-polyol artificial blood substitutes. , 1973, The New England journal of medicine.

[39]  Shelton D Caruthers,et al.  Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents. , 2007, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[40]  Zhong-Xing Jiang,et al.  The synthesis of a geminally perfluoro-tert-butylated beta-amino acid and its protected forms as a potential pharmacokinetic modulator and reporter for peptide-based pharmaceuticals. , 2007, The Journal of organic chemistry.

[41]  R. Deichmann,et al.  Perfluoro-15-crown-5-ether labelled macrophages in adoptive transfer experimental allergic encephalomyelitis. , 1997, Artificial cells, blood substitutes, and immobilization biotechnology.

[42]  D. Collins,et al.  The quantitative 19F-imaging of albumin at 1.5 T: a potential in-vivo tool. , 2001, Magnetic resonance imaging.

[43]  J. Riess,et al.  Understanding the Fundamentals of Perfluorocarbons and Perfluorocarbon Emulsions Relevant to In Vivo Oxygen Delivery , 2005, Artificial cells, blood substitutes, and immobilization biotechnology.

[44]  István Kövesdi,et al.  An improved design of fluorophilic molecules: prediction of the ln P fluorous partition coefficient, fluorophilicity, using 3D QSAR descriptors and neural networks , 2001 .

[45]  R. Hurd,et al.  19F relaxation rate enhancement and frequency shift with Gd-DTPA. , 1989, Investigative radiology.

[46]  M. Wendland,et al.  Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations. , 2007, Biomacromolecules.

[47]  S. Caruthers,et al.  Gadolinium‐modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging , 2008, Magnetic resonance in medicine.

[48]  Rolf Schubert,et al.  In Vivo Monitoring of Inflammation After Cardiac and Cerebral Ischemia by Fluorine Magnetic Resonance Imaging , 2008, Circulation.

[49]  J. Rábai,et al.  Novel generation ponytails in fluorous chemistry: Syntheses of primary, secondary, and tertiary (nonafluoro-tert-butyloxy)ethyl amines , 2006 .

[50]  T. Csóka,et al.  Synthesis of optically active α-(nonafluoro-tert-butoxy)carboxylic acids , 2013 .

[51]  S. Caruthers,et al.  19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  Enzo Terreno,et al.  Tunable imaging of cells labeled with MRI-PARACEST agents. , 2005, Angewandte Chemie.

[53]  Mangala Srinivas,et al.  Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection. , 2008, Journal of the American Chemical Society.

[54]  Paul A. Bottomley,et al.  19F magnetic resonance imaging , 1977 .

[55]  M. Spiller,et al.  Evidence for weak protein binding of commercial extracellular gadolinium contrast agents , 2010, Magnetic resonance in medicine.

[56]  Alan Koretsky,et al.  Micro-engineered local field control for high-sensitivity multispectral MRI , 2008, Nature.

[57]  Y. Yu,et al.  Fluorous mixture synthesis of asymmetric dendrimers. , 2010, The Journal of organic chemistry.

[58]  E. Ahrens,et al.  Fluorine-containing nanoemulsions for MRI cell tracking. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[59]  Eun-Kee Jeong,et al.  Symmetry-guided design and fluorous synthesis of a stable and rapidly excreted imaging tracer for (19)F MRI. , 2009, Angewandte Chemie.

[60]  H. Sloviter,et al.  Erythrocyte Substitute for Perfusion of Brain , 1967, Nature.

[61]  Y. B. Yu,et al.  Separation of Fluorinated Amino Acids and Oligopeptides from their Non-fluorinated Counterparts using High-performance Liquid Chromatography. , 2010, Journal of fluorine chemistry.

[62]  A. Whittaker,et al.  Synthesis and evaluation of partly fluorinated block copolymers as MRI imaging agents. , 2009, Biomacromolecules.

[63]  Samuel A Wickline,et al.  Targeted ultrasonic contrast agents for molecular imaging and therapy. , 2001, Current problems in cardiology.

[64]  D. Tomalia,et al.  Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. , 2001, Drug discovery today.

[65]  R. Damadian.  Tumor Detection by Nuclear Magnetic Resonance , 1971, Science.

[66]  Y. B. Yu.  Fluorocarbon nanoparticles as multifunctional drug delivery vehicles , 2006, Journal of drug targeting.

[67]  Y. Yu,et al.  The Effect of Column and Eluent Fluorination on the Retention and Separation of non-Fluorinated Amino Acids and Proteins by HPLC. , 2011, Journal of fluorine chemistry.

[68]  Fluorinated contrast agents for magnetic resonance imaging; a review of recent developments , 2011 .

[69]  Arend Heerschap,et al.  (19)F MRI for quantitative in vivo cell tracking. , 2010, Trends in biotechnology.

[70]  Andrew M Blamire,et al.  19F‐lanthanide complexes with increased sensitivity for 19F‐MRI: Optimization of the MR acquisition , 2011, Magnetic resonance in medicine.

[71]  Zhong-Xing Jiang,et al.  The Design and Synthesis of Highly Branched and Spherically Symmetric Fluorinated Oils and Amphiles. , 2007, Tetrahedron.

[72]  P. Lauterbur,et al.  Image Formation by Induced Local Interactions: Examples Employing Nuclear Magnetic Resonance , 1973, Nature.

[73]  F. Gollan,et al.  Survival of Mammals Breathing Organic Liquids Equilibrated with Oxygen at Atmospheric Pressure , 1966, Science.

[74]  Zhong-Xing Jiang,et al.  Enantioselective synthesis of (2R, 3S)‐ and (2S, 3R)‐4,4,4‐trifluoro‐N‐Fmoc‐O‐tert‐butyl‐threonine and their racemization‐free incorporation into oligopeptides via solid‐phase synthesis , 2007, Biopolymers.

[75]  Zhuxian Zhou,et al.  Gadolinium-based contrast agents for magnetic resonance cancer imaging. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[76]  D. Laidlaw,et al.  In vivo cytometry of antigen‐specific t cells using 19F MRI , 2009, Magnetic resonance in medicine.

[77]  D. Zhu.  A novel reaction medium : perfluorocarbon fluids , 1993 .